Trial intelligence / Profile preview

Lithium for Suicidal Behavior in Mood Disorders

NCT01928446Phase 3Terminated

Sponsor
VA Office of Research & Development
Start
Jul 2015
Primary completion
Aug 2019
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 3 trial of lithium in Suicidal Behavior (SB), sponsored by VA Office of Research & Development. Started Jul 2015; status: terminated.

02

Drugs

lithium
03

Conditions

Suicidal Behavior (SB)

Beyond the preview

Go deeper on NCT01928446.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01928446.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call